OneAlphaMed combined KOL advocacy, decentralized sales activation, and a dynamic content routing system to deliver a perfectly synchronized omnichannel product launch for 25,000+ HCPs.
Industry / Specialty
Pharmaceutical & Healthcare
Scale / Audience
15,000+ HCPs
Core Solutions
Co-created Certification
Time to Value
Pan-India Deployment
Stop funding clicks. Start building undisputed credibility for your brand today.
Launching a new contraceptive into a saturated gynecology market requires more than an impressive kickoff webinar and a strong sales force. It requires a completely unified narrative — delivered consistently across every channel, at every touchpoint, to every audience segment — from the moment a gynecologist first hears the brand name. OneAlphaMed engineered a true omnichannel ‘surround-sound’ launch architecture for 25,000+ HCPs, synchronizing top-tier KOL scientific endorsements with precision-segmented digital content and fully coordinated field force activation to achieve a unified, inescapable brand narrative from Day 1.
Pharmaceutical product launches typically fail not because of poor individual channel execution, but because channels operate in silos — each delivering a slightly different version of the brand story.
During pre-launch strategy audits, OneAlphaMed found that the sales force, digital email campaigns, and KOL speaker presentations were all emphasizing different primary benefit claims — creating a fragmented, contradictory brand impression for HCPs who encountered the product across multiple touchpoints. This inconsistency is a primary driver of physician confusion and launch underperformance.
Previous launches by the brand had relied disproportionately on physical sales force relationships — a strategy that missed an increasingly large, digital-first segment of younger gynecologists and general practitioners who had limited or no interaction with the company's field team but were highly active consumers of digital clinical content.
The HCP audience for a new contraceptive spans highly specialized urban gynecologists, suburban general practitioners managing a broad mix of patient needs, and rural or semi-urban doctors with very different clinical infrastructure and patient population characteristics. Delivering identical messaging across this spectrum consistently resulted in content perceived as either too technical or insufficiently evidence-based depending on the recipient's profile.
OneAlphaMed designed a launch architecture where digital, field, and KOL channels did not merely coexist — they actively amplified each other.
OneAlphaMed's Medical Affairs team developed a single, rigorously evidence-based scientific master narrative for the launch — a definitive claim hierarchy built from the clinical trial data, with a clear primary benefit claim, supporting secondary claims, and a validated patient profiling guide. This master narrative was then translated into channel-specific formats — never altered in substance, only in presentation depth and format.
A detailed HCP database segmentation was implemented across the brand's CRM, classifying gynecologists by specialty depth, digital engagement history, urban/rural classification, and patient volume indicators. Dynamic content routing ensured that clinical subspecialists received detailed mechanistic data and comparative efficacy information, while general practitioners received simplified patient profiling guides and high-quality patient education support materials.
OneAlphaMed engineered a synchronized deployment calendar ensuring that digital content 'pre-warmed' each HCP segment with relevant brand education before field rep visits, that KOL webinars were scheduled to coincide with the peak of digital engagement activity, and that field force leave-behind materials precisely mirrored the digital assets the HCP had already received — creating the 'surround-sound' effect of comprehensive, consistent brand immersion.
The Surround-Sound Effect.
The transformation was conceptual before it was tactical. By establishing an inviolable principle — that physical and digital channels must actively reinforce each other, not merely coexist — OneAlphaMed created a launch architecture where every HCP touchpoint built on the last. The result was that HCPs did not simply receive a product launch; they experienced a coordinated, scientifically consistent narrative that made the brand feel like the inevitable, evidence-based choice in their prescribing decision.
The omnichannel architecture delivered a flawless, high-impact launch — achieving reach, recall, and conversion metrics that set a new benchmark for the brand's portfolio.
The launch created a documented, measurable shift in how gynecologists and general practitioners engaged with the brand — and with the category.
Experienced a coherent, highly relevant and personalized learning journey — whether speaking with a field representative, attending a KOL-led webinar, or receiving a WhatsApp clinical update. The consistency of the brand message across all touchpoints dramatically increased prescription confidence and reduced the cognitive effort required to evaluate the new product against existing alternatives.
Entered every clinical visit knowing that the target HCP had already been 'scientifically pre-warmed' by a coordinated sequence of high-quality digital brand education. This prior digital engagement transformed cold sales calls into informed clinical conversations, improving rep confidence, HCP meeting quality, and prescription intent conversion rates.
Achieved the industry's most difficult launch objective: perfect message consistency across all touchpoints, at scale, across a heterogeneous HCP audience. Post-launch brand perception surveys documented a significant increase in the brand's 'scientific credibility' and 'differentiated clinical value' scores — the two metrics most predictive of long-term prescription behavior.
Dynamic routing means that our integrated CRM system automatically selects and deploys the appropriate content variant — from the pre-approved scientific content library — based on the HCP's real-time segmentation profile. Trigger variables include specialty type, last digital engagement date and content type, field rep visit history, geography, and practice setting. The system updates routing decisions in near-real-time as new engagement data is generated.
KOL engagement was structured in three phases: pre-launch advisory (scientific advisory board reviewing the launch narrative and providing endorsement), launch amplification (KOL-led national webinar timed to coincide with the peak of initial digital engagement activity), and post-launch reinforcement (KOL-authored scientific commentaries deployed via digital channels 30 and 60 days post-launch to sustain momentum). All KOL activities were managed under compliant engagement contracts with full transparency disclosures.
Yes. We implement a multi-touch attribution model that tracks individual HCP engagement journeys across all channels simultaneously — mapping which digital assets were viewed before, during, and after field visits; which email or WhatsApp content preceded KOL webinar attendance; and which combination of touchpoints correlated most strongly with prescription intent conversion. This cross-channel attribution data is delivered in a monthly brand performance dashboard.
+91 9811660635
info@onealphamed.com
2414, Ground Floor, Aravali Vihar, Sector 49 Faridabad, Haryana – 121001 India
Copyright © 2026 OneAlphaMed. All Rights Reserved.